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18CEEMI T PRE-DIGCBARGE STRESS TEOT 
G 8Y8TE TBROXBOLYSIS: TEE GISSI-2 
IRE8 RESULTS. 
GIBSI-2 IRE8 (1scbania Residua) study Group. 
IRES study prospectively enrolled 454 un- 
ected GISSI-2 pts aged (70 yrs 24 hrs follow- 
ing their first MI; 386 of them underwent a pre- 
discharge,off drug symptom-limited exercise test 
(ET) and in 360/386 (93%) pts a pre-discharge 
coronary angiography was also performed. A posi- 
tive ET was found in 104 (27%) pts (angina in 31 
and/or >lmm ST depression in 87), unrelated to 
sex,age, Q/non Q MI, thrombolytic agent (52% SK, 
48% tPA) and time (l-6 hrs) of administration. A 
greater incidence of positive ET was found 
following inferior (32%) vs anterior MI 
(18%,peO.O5) and in pts with multiple (47%) vs 
single (27%,p<O.O1) ~70% coronary stenosis. The 
6-month follow-up was completed in 3111320 (97%) 
pts with diagnostic (positive/negative) ET:CABG 
or PTCA were carried out in 36% of positive and 
3.7% negative ET(p<O.Ol).Out of 278 medically 
treated pts, cardiac events (CE:4 deaths,13 non- 
fatal re-MI and 30 angina) occur&d in 32% posi- 
tive vs 12% (pcO.001) negative ET (angina: 
p<O.OOlt death and re-MI:NS).CE occurred in RF;.% 
of pts wit‘* positive and in 15% with negative ET 
following anterior MI (NS) and in 31% positive 
vs 9.6% negative ET following inferior MI 
(PCO.01). In 201 pts with single CAD,CE occurred 
in 17% positive vs 8% negative ET (NS): in 92 
pts with multivessel CAD,CE were found in 50% 
positive vs 9% negative ET (pcO.001). Prelimi- 
nary GISSIZ-IRES results confirm,even following 
throxnbolysis, the prognostic value of a positive 
ET in pts with inferior MI and/or multiple CAD. 
EFFECTS OF SARUPLASE AND OF ALTEPLASE ON HEMOSTASIS IN 
PATIENTS WITH ACUTE MYOCARDIAL INFARCTION. A SINGLE-BLIND, 
RANDOMIZED TRIAL 
Philippe Vanhove, and the Belgian Saruplase Alteplase 
Trial Group, Center for Thrombosis and Vascular Research, 
University of Leuven, Leuven, Belgium 
The effects of saruplase (S! and alteplase (A) on 
hemostasis were compared in patients with acute myocardial 
infarction treated randomly, either with intravenous 
(i.v.1 S (bolus of 20 mg, then 60 mg in 1 h; n=24) or with 
i.v. A (bolus of 10 mg, then 50 mg in 1 h and 40 mg in 2 
h; n=28). 1-v. heparin was given in all patients. 
Before End of End End 
treatment treatment +l h +8 to 24 h 
Fibrinogen* (g/l) S 2.35 0.90-- 0.50 1.08 
- (Fg) 
Plasmlnogen+ (%I t 
2.50 1.80 1.90 1.95 
88 28 21 34 
(Plgl A aa 47 50 59 
a -Antiplasmin*(%)S 
3 ) A 
100 28 50 68 
FDPs* a2-$P S 
102 52 a3 87 
1.5 114 368 123 
fug/ml) A 1.9 27 55 29 
D-dimer* (ug/ml) S 0.30 2.76 4.21 1.65 
A 0.14 3.49 4.56 0.95 
*Values represent medians. +Fibrin(ogenl degradation 
products. 
Bleeding was observed in 5 and 8 patients of the ‘S and A 
iiwups , respectively (not significant). 
Conclusion: Posttreatment Fg, Plg and a -AP levels were 
significantly higher and FDPs significant y ? lower in the A 
group than in the S group. Posttreatment D-dimer levels 
were not significantly different between treatment groups. 
S induced more extensive hemostatic breakdown than A. In 
contrast, bleeding complications tended to be more 
frequent in the A group. 
THE HBMODYNAMIC EFFECTS 
VENTRICULAR INFARCTION 
OF CORONARY RBPERPUSION IN RIGHT 
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, Joeeph G. Samyn,M.D., Craig 
Neuner,X.D., David 6. Rizik,H.D., William W. 
O'Neill.U.D., FAcco William Beaumont Hoepital, Royal 
Oak, Michigan 
accompanied by acute RV 
e hemodynamic eeguelae and may 
The hemodynamic effects of 
ion are not well undettatood. 
MI over a 16 month period. 
Inclueion criteria required 1) an acute inferior wall MI 
by ECG, 2) an elevated RR preeeure 2 10 mmWg, 3) 
noninvaeive atudiee e 
underwent right and 1 
consisted of 13 pte w 
or thrombolytic reperfusion, and Group 8, of 14 pte who 
Hemodynamice 
dge preeeure (PCWP)) were 
n at 8 houro. 
Group A Group B 
RBBULTB 
Mean age (yeare) 
'g;' ';;';I 
MAP ( 80 mm?Ig*** 5/;3 
nultiveseel dieeaee 6/13 
wi:' 
Hean CK peak (I.U.) 2094 1786 
Initial RR (mmHg) (mean) 15.6 13.8 
RA (8 hre) (mmHg) (mean) 8.0 13.3** 
Change in RA @Wig) (mean) -7.4 =0.6** 
Initial PCNP (m&g) (mean) 15.8 12.6 
PCNP (8 hrs) (mnHg) (mean) 10.1 13.0* 
Change in PCWP (mean) -6.0 +0.3* 
Survival until discharge 12/13 (92%) 9/14 (64%) 
* p ( 0.05 ** p s 0.01 
*** mean arterial preeeure at preeentation 
Variablee euch as meaeurement of fluid balance, 
intravenoue nitroglyercin or inotropic agents, 
of an IABP did not differ eisnificantly between the 
group0 * 
Succeseful reperfueion in the eetting of RV 
MI correlate8 with rapid hemodynamic improvement and a 
trend toward improved eurvival. 
O~~~~~Al~E~l TO REPERFUSION 
ARDIAL IN ON 
RECEIVING STREPT SE OR SUE PLAS EN 
ACTIVATOR. 
Prediman K. Shah. M.D Allan S. Lew, M.D., Bojan 
Cercek, M.D., William G$it, M.D. Cedars-Sinai Medical 
Center, and University of California, Los Angeles, CA. 
The 24 hr reperfusion (REP) rates in pts with acute 
myocardial infarction (AM1 are similar with tissue 
plasminogen activator (TPA 1 and Streptokinase (SK) 
despite a significally higher REP with TPA at 90 mins. 
This indicates that REP occurs frequently >90 mins 
after start of SK. To examine this possibility we 
reviewed 66 pts treated with SK and 44 pts treated 
with TPA who manifested signs of successful REP and 
were carefully observed for upto 3 hours after 
treatment. Creatine kinase (CK) levels and ECG's were 
taken at 15-30 min intervals. REP was diagnosed when 
ST segment elevation resolved rapidly (by 2 50% within 
15+10 mins) and CK increased abruptly (by 213% of peak 
in the first hour). The diagnostic value of rapid CK 
rise for REP was previously angiographtcally validated 
during an intracoronary SK study. Time of REP was 
defined as the time of onset of the resolution of ST 
segment elevation. The time to REP averaged 55 2 33 
mins in the SK and 48 + 22 mins in the TPA group 
(p=NSl. The time to REP \?as >90 mins (Range:95140 
mins) in 13/66 (20%) tKlpuatiients and in only l/44 (2%) 
TPA pts (p=O.Ol). Co c s on: Our data show that in 
a significant proportion (20%) of pts with AM1 
receiving SK, reperfusion occurs > 90 mins but < 150 
mins after start of treatment, probably still early 
enough to affect myocardial salvage. This observation 
may, at least in part, explain the similarity of early 
mortality rates despite a significant difference in 
REP rates at 90 mins after start of treatment. 
